| Previous Close | 1,001.30 |
| Open | 1,002.54 |
| Bid | 1,000.14 x 100 |
| Ask | 1,000.47 x 100 |
| Day's Range | 998.02 - 1,004.23 |
| 52 Week Range | 682.12 - 1,017.00 |
| Volume | 902,729 |
| Avg. Volume | 3,835,193 |
| Market Cap | 478.64B |
| Beta | 1.41 |
| PE Ratio (TTM) | 188.59 |
| EPS (TTM) | 5.31 |
| Earnings Date | Jul 26, 2017 - Jul 31, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1,115.31 |
Editor's PickYahoo Finance Video•5 hours agoYahoo Finance Live: Market Movers - Jun 23rd, 2017
Yahoo Finance's LIVE stock market coverage and analysis.
Editor's PickYahoo Finance Video•2 days agoStocks struggle to find direction as investors watch oil; Travis Kalanick out as Uber CEO
Wall Street is looking a little wobbly. Stocks opened mixed as oil prices stabilize after sinking into bear market territory as supply concerns resurfaced on Tuesday. Alexis Christoforous, Rick Newman, Jared Blikre and Dan Roberts discuss the day's top business stories, including the resignation of Uber CEO Travis Kalanick. Where does Uber go from here?
- American City Business Journals•14 minutes ago
Ed Goldman: Amazon, Whole Foods and drugs: Who could ask for anything more?
Almost lost in the announcement late last week that Amazon was buying Whole Foods was the simultaneous buzz about the cyber giant’s desire to get into the prescription drug business. As Ira Flatow remarked on Public Radio International’s “Science Friday,” this could be another example of Amazon.com Inc.’s (AMZN) “disrupting” of traditional business models — and, in practice, could even drive down the price of drugs since Amazon would be able to negotiate with manufacturers and buy them in bulk.
